Report Overview:
The Global Allogeneic Stem Cell Transplantation Market Size was estimated at USD 1062.20 million in 2023 and is projected to reach USD 1506.76 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Allogeneic Stem Cell Transplantation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Allogeneic Stem Cell Transplantation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Allogeneic Stem Cell Transplantation market in any manner.
Global Allogeneic Stem Cell Transplantation Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Mesoblast Limited
Gamida Cell Ltd.
Novartis International AG
Cellectis SA
Magenta Therapeutics Inc.
Fate Therapeutics Inc.
Cynata Therapeutics Limited
Kiadis Pharma N.V
Takeda Pharmaceutical Company Limited
JCR Pharmaceuticals Co., Ltd.
Pluristem Therapeutics Inc.
Celularity Inc.
Lineage Cell Therapeutics Inc.
Nohla Therapeutics Inc.
Orchard Therapeutics Plc
Market Segmentation (by Type)
Unmodified Stem Cell Transplant
T-cell Depleted Transplant
Cord Blood Transplant
Donor Lymphocyte Infusion
Market Segmentation (by Application)
Hospital
Ambulatory Surgical Center
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Allogeneic Stem Cell Transplantation Market
? Overview of the regional outlook of the Allogeneic Stem Cell Transplantation Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Allogeneic Stem Cell Transplantation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Allogeneic Stem Cell Transplantation
1.2 Key Market Segments
1.2.1 Allogeneic Stem Cell Transplantation Segment by Type
1.2.2 Allogeneic Stem Cell Transplantation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Allogeneic Stem Cell Transplantation Market Overview
2.1 Global Market Overview
2.1.1 Global Allogeneic Stem Cell Transplantation Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Allogeneic Stem Cell Transplantation Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Allogeneic Stem Cell Transplantation Market Competitive Landscape
3.1 Global Allogeneic Stem Cell Transplantation Sales by Manufacturers (2019-2024)
3.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Manufacturers (2019-2024)
3.3 Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Allogeneic Stem Cell Transplantation Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Allogeneic Stem Cell Transplantation Sales Sites, Area Served, Product Type
3.6 Allogeneic Stem Cell Transplantation Market Competitive Situation and Trends
3.6.1 Allogeneic Stem Cell Transplantation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Allogeneic Stem Cell Transplantation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Allogeneic Stem Cell Transplantation Industry Chain Analysis
4.1 Allogeneic Stem Cell Transplantation Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Allogeneic Stem Cell Transplantation Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Allogeneic Stem Cell Transplantation Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Allogeneic Stem Cell Transplantation Sales Market Share by Type (2019-2024)
6.3 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2019-2024)
6.4 Global Allogeneic Stem Cell Transplantation Price by Type (2019-2024)
7 Allogeneic Stem Cell Transplantation Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Allogeneic Stem Cell Transplantation Market Sales by Application (2019-2024)
7.3 Global Allogeneic Stem Cell Transplantation Market Size (M USD) by Application (2019-2024)
7.4 Global Allogeneic Stem Cell Transplantation Sales Growth Rate by Application (2019-2024)
8 Allogeneic Stem Cell Transplantation Market Segmentation by Region
8.1 Global Allogeneic Stem Cell Transplantation Sales by Region
8.1.1 Global Allogeneic Stem Cell Transplantation Sales by Region
8.1.2 Global Allogeneic Stem Cell Transplantation Sales Market Share by Region
8.2 North America
8.2.1 North America Allogeneic Stem Cell Transplantation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Allogeneic Stem Cell Transplantation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Allogeneic Stem Cell Transplantation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Allogeneic Stem Cell Transplantation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Allogeneic Stem Cell Transplantation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Mesoblast Limited
9.1.1 Mesoblast Limited Allogeneic Stem Cell Transplantation Basic Information
9.1.2 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Overview
9.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.1.4 Mesoblast Limited Business Overview
9.1.5 Mesoblast Limited Allogeneic Stem Cell Transplantation SWOT Analysis
9.1.6 Mesoblast Limited Recent Developments
9.2 Gamida Cell Ltd.
9.2.1 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Basic Information
9.2.2 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Overview
9.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Market Performance
9.2.4 Gamida Cell Ltd. Business Overview
9.2.5 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation SWOT Analysis
9.2.6 Gamida Cell Ltd. Recent Developments
9.3 Novartis International AG
9.3.1 Novartis International AG Allogeneic Stem Cell Transplantation Basic Information
9.3.2 Novartis International AG Allogeneic Stem Cell Transplantation Product Overview
9.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Product Market Performance
9.3.4 Novartis International AG Allogeneic Stem Cell Transplantation SWOT Analysis
9.3.5 Novartis International AG Business Overview
9.3.6 Novartis International AG Recent Developments
9.4 Cellectis SA
9.4.1 Cellectis SA Allogeneic Stem Cell Transplantation Basic Information
9.4.2 Cellectis SA Allogeneic Stem Cell Transplantation Product Overview
9.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Product Market Performance
9.4.4 Cellectis SA Business Overview
9.4.5 Cellectis SA Recent Developments
9.5 Magenta Therapeutics Inc.
9.5.1 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.5.2 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.5.4 Magenta Therapeutics Inc. Business Overview
9.5.5 Magenta Therapeutics Inc. Recent Developments
9.6 Fate Therapeutics Inc.
9.6.1 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.6.2 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.6.4 Fate Therapeutics Inc. Business Overview
9.6.5 Fate Therapeutics Inc. Recent Developments
9.7 Cynata Therapeutics Limited
9.7.1 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Basic Information
9.7.2 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Overview
9.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.7.4 Cynata Therapeutics Limited Business Overview
9.7.5 Cynata Therapeutics Limited Recent Developments
9.8 Kiadis Pharma N.V
9.8.1 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Basic Information
9.8.2 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Overview
9.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Market Performance
9.8.4 Kiadis Pharma N.V Business Overview
9.8.5 Kiadis Pharma N.V Recent Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Basic Information
9.9.2 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Overview
9.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Market Performance
9.9.4 Takeda Pharmaceutical Company Limited Business Overview
9.9.5 Takeda Pharmaceutical Company Limited Recent Developments
9.10 JCR Pharmaceuticals Co., Ltd.
9.10.1 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Basic Information
9.10.2 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Overview
9.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Market Performance
9.10.4 JCR Pharmaceuticals Co., Ltd. Business Overview
9.10.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
9.11 Pluristem Therapeutics Inc.
9.11.1 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.11.2 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.11.4 Pluristem Therapeutics Inc. Business Overview
9.11.5 Pluristem Therapeutics Inc. Recent Developments
9.12 Celularity Inc.
9.12.1 Celularity Inc. Allogeneic Stem Cell Transplantation Basic Information
9.12.2 Celularity Inc. Allogeneic Stem Cell Transplantation Product Overview
9.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.12.4 Celularity Inc. Business Overview
9.12.5 Celularity Inc. Recent Developments
9.13 Lineage Cell Therapeutics Inc.
9.13.1 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.13.2 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.13.4 Lineage Cell Therapeutics Inc. Business Overview
9.13.5 Lineage Cell Therapeutics Inc. Recent Developments
9.14 Nohla Therapeutics Inc.
9.14.1 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
9.14.2 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
9.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Market Performance
9.14.4 Nohla Therapeutics Inc. Business Overview
9.14.5 Nohla Therapeutics Inc. Recent Developments
9.15 Orchard Therapeutics Plc
9.15.1 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Basic Information
9.15.2 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Overview
9.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Market Performance
9.15.4 Orchard Therapeutics Plc Business Overview
9.15.5 Orchard Therapeutics Plc Recent Developments
10 Allogeneic Stem Cell Transplantation Market Forecast by Region
10.1 Global Allogeneic Stem Cell Transplantation Market Size Forecast
10.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Allogeneic Stem Cell Transplantation Market Size Forecast by Country
10.2.3 Asia Pacific Allogeneic Stem Cell Transplantation Market Size Forecast by Region
10.2.4 South America Allogeneic Stem Cell Transplantation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Allogeneic Stem Cell Transplantation by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Allogeneic Stem Cell Transplantation Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Allogeneic Stem Cell Transplantation by Type (2025-2030)
11.1.2 Global Allogeneic Stem Cell Transplantation Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Allogeneic Stem Cell Transplantation by Type (2025-2030)
11.2 Global Allogeneic Stem Cell Transplantation Market Forecast by Application (2025-2030)
11.2.1 Global Allogeneic Stem Cell Transplantation Sales (K Units) Forecast by Application
11.2.2 Global Allogeneic Stem Cell Transplantation Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Allogeneic Stem Cell Transplantation Market Size Comparison by Region (M USD)
Table 5. Global Allogeneic Stem Cell Transplantation Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Allogeneic Stem Cell Transplantation Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Allogeneic Stem Cell Transplantation Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Allogeneic Stem Cell Transplantation Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2022)
Table 10. Global Market Allogeneic Stem Cell Transplantation Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Allogeneic Stem Cell Transplantation Sales Sites and Area Served
Table 12. Manufacturers Allogeneic Stem Cell Transplantation Product Type
Table 13. Global Allogeneic Stem Cell Transplantation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Allogeneic Stem Cell Transplantation
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Allogeneic Stem Cell Transplantation Market Challenges
Table 22. Global Allogeneic Stem Cell Transplantation Sales by Type (K Units)
Table 23. Global Allogeneic Stem Cell Transplantation Market Size by Type (M USD)
Table 24. Global Allogeneic Stem Cell Transplantation Sales (K Units) by Type (2019-2024)
Table 25. Global Allogeneic Stem Cell Transplantation Sales Market Share by Type (2019-2024)
Table 26. Global Allogeneic Stem Cell Transplantation Market Size (M USD) by Type (2019-2024)
Table 27. Global Allogeneic Stem Cell Transplantation Market Size Share by Type (2019-2024)
Table 28. Global Allogeneic Stem Cell Transplantation Price (USD/Unit) by Type (2019-2024)
Table 29. Global Allogeneic Stem Cell Transplantation Sales (K Units) by Application
Table 30. Global Allogeneic Stem Cell Transplantation Market Size by Application
Table 31. Global Allogeneic Stem Cell Transplantation Sales by Application (2019-2024) & (K Units)
Table 32. Global Allogeneic Stem Cell Transplantation Sales Market Share by Application (2019-2024)
Table 33. Global Allogeneic Stem Cell Transplantation Sales by Application (2019-2024) & (M USD)
Table 34. Global Allogeneic Stem Cell Transplantation Market Share by Application (2019-2024)
Table 35. Global Allogeneic Stem Cell Transplantation Sales Growth Rate by Application (2019-2024)
Table 36. Global Allogeneic Stem Cell Transplantation Sales by Region (2019-2024) & (K Units)
Table 37. Global Allogeneic Stem Cell Transplantation Sales Market Share by Region (2019-2024)
Table 38. North America Allogeneic Stem Cell Transplantation Sales by Country (2019-2024) & (K Units)
Table 39. Europe Allogeneic Stem Cell Transplantation Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Allogeneic Stem Cell Transplantation Sales by Region (2019-2024) & (K Units)
Table 41. South America Allogeneic Stem Cell Transplantation Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Allogeneic Stem Cell Transplantation Sales by Region (2019-2024) & (K Units)
Table 43. Mesoblast Limited Allogeneic Stem Cell Transplantation Basic Information
Table 44. Mesoblast Limited Allogeneic Stem Cell Transplantation Product Overview
Table 45. Mesoblast Limited Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Mesoblast Limited Business Overview
Table 47. Mesoblast Limited Allogeneic Stem Cell Transplantation SWOT Analysis
Table 48. Mesoblast Limited Recent Developments
Table 49. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Basic Information
Table 50. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Overview
Table 51. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Gamida Cell Ltd. Business Overview
Table 53. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation SWOT Analysis
Table 54. Gamida Cell Ltd. Recent Developments
Table 55. Novartis International AG Allogeneic Stem Cell Transplantation Basic Information
Table 56. Novartis International AG Allogeneic Stem Cell Transplantation Product Overview
Table 57. Novartis International AG Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Novartis International AG Allogeneic Stem Cell Transplantation SWOT Analysis
Table 59. Novartis International AG Business Overview
Table 60. Novartis International AG Recent Developments
Table 61. Cellectis SA Allogeneic Stem Cell Transplantation Basic Information
Table 62. Cellectis SA Allogeneic Stem Cell Transplantation Product Overview
Table 63. Cellectis SA Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cellectis SA Business Overview
Table 65. Cellectis SA Recent Developments
Table 66. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 67. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 68. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Magenta Therapeutics Inc. Business Overview
Table 70. Magenta Therapeutics Inc. Recent Developments
Table 71. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 72. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 73. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fate Therapeutics Inc. Business Overview
Table 75. Fate Therapeutics Inc. Recent Developments
Table 76. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Basic Information
Table 77. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Overview
Table 78. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cynata Therapeutics Limited Business Overview
Table 80. Cynata Therapeutics Limited Recent Developments
Table 81. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Basic Information
Table 82. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Overview
Table 83. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kiadis Pharma N.V Business Overview
Table 85. Kiadis Pharma N.V Recent Developments
Table 86. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Basic Information
Table 87. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Overview
Table 88. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Recent Developments
Table 91. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Basic Information
Table 92. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Overview
Table 93. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 95. JCR Pharmaceuticals Co., Ltd. Recent Developments
Table 96. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 97. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 98. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pluristem Therapeutics Inc. Business Overview
Table 100. Pluristem Therapeutics Inc. Recent Developments
Table 101. Celularity Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 102. Celularity Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 103. Celularity Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Celularity Inc. Business Overview
Table 105. Celularity Inc. Recent Developments
Table 106. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 107. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 108. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Lineage Cell Therapeutics Inc. Business Overview
Table 110. Lineage Cell Therapeutics Inc. Recent Developments
Table 111. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Basic Information
Table 112. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Overview
Table 113. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Nohla Therapeutics Inc. Business Overview
Table 115. Nohla Therapeutics Inc. Recent Developments
Table 116. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Basic Information
Table 117. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Overview
Table 118. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Orchard Therapeutics Plc Business Overview
Table 120. Orchard Therapeutics Plc Recent Developments
Table 121. Global Allogeneic Stem Cell Transplantation Sales Forecast by Region (2025-2030) & (K Units)
Table 122. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Allogeneic Stem Cell Transplantation Sales Forecast by Country (2025-2030) & (K Units)
Table 124. North America Allogeneic Stem Cell Transplantation Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Allogeneic Stem Cell Transplantation Sales Forecast by Country (2025-2030) & (K Units)
Table 126. Europe Allogeneic Stem Cell Transplantation Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Allogeneic Stem Cell Transplantation Sales Forecast by Region (2025-2030) & (K Units)
Table 128. Asia Pacific Allogeneic Stem Cell Transplantation Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Allogeneic Stem Cell Transplantation Sales Forecast by Country (2025-2030) & (K Units)
Table 130. South America Allogeneic Stem Cell Transplantation Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Allogeneic Stem Cell Transplantation Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Allogeneic Stem Cell Transplantation Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Allogeneic Stem Cell Transplantation Sales Forecast by Type (2025-2030) & (K Units)
Table 134. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Allogeneic Stem Cell Transplantation Price Forecast by Type (2025-2030) & (USD/Unit)
Table 136. Global Allogeneic Stem Cell Transplantation Sales (K Units) Forecast by Application (2025-2030)
Table 137. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Allogeneic Stem Cell Transplantation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Allogeneic Stem Cell Transplantation Market Size (M USD), 2019-2030
Figure 5. Global Allogeneic Stem Cell Transplantation Market Size (M USD) (2019-2030)
Figure 6. Global Allogeneic Stem Cell Transplantation Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Allogeneic Stem Cell Transplantation Market Size by Country (M USD)
Figure 11. Allogeneic Stem Cell Transplantation Sales Share by Manufacturers in 2023
Figure 12. Global Allogeneic Stem Cell Transplantation Revenue Share by Manufacturers in 2023
Figure 13. Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Allogeneic Stem Cell Transplantation Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Allogeneic Stem Cell Transplantation Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Allogeneic Stem Cell Transplantation Market Share by Type
Figure 18. Sales Market Share of Allogeneic Stem Cell Transplantation by Type (2019-2024)
Figure 19. Sales Market Share of Allogeneic Stem Cell Transplantation by Type in 2023
Figure 20. Market Size Share of Allogeneic Stem Cell Transplantation by Type (2019-2024)
Figure 21. Market Size Market Share of Allogeneic Stem Cell Transplantation by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Allogeneic Stem Cell Transplantation Market Share by Application
Figure 24. Global Allogeneic Stem Cell Transplantation Sales Market Share by Application (2019-2024)
Figure 25. Global Allogeneic Stem Cell Transplantation Sales Market Share by Application in 2023
Figure 26. Global Allogeneic Stem Cell Transplantation Market Share by Application (2019-2024)
Figure 27. Global Allogeneic Stem Cell Transplantation Market Share by Application in 2023
Figure 28. Global Allogeneic Stem Cell Transplantation Sales Growth Rate by Application (2019-2024)
Figure 29. Global Allogeneic Stem Cell Transplantation Sales Market Share by Region (2019-2024)
Figure 30. North America Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Allogeneic Stem Cell Transplantation Sales Market Share by Country in 2023
Figure 32. U.S. Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Allogeneic Stem Cell Transplantation Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Allogeneic Stem Cell Transplantation Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Allogeneic Stem Cell Transplantation Sales Market Share by Country in 2023
Figure 37. Germany Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Allogeneic Stem Cell Transplantation Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Allogeneic Stem Cell Transplantation Sales Market Share by Region in 2023
Figure 44. China Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Allogeneic Stem Cell Transplantation Sales and Growth Rate (K Units)
Figure 50. South America Allogeneic Stem Cell Transplantation Sales Market Share by Country in 2023
Figure 51. Brazil Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Allogeneic Stem Cell Transplantation Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Allogeneic Stem Cell Transplantation Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Allogeneic Stem Cell Transplantation Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Allogeneic Stem Cell Transplantation Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Allogeneic Stem Cell Transplantation Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Allogeneic Stem Cell Transplantation Market Share Forecast by Type (2025-2030)
Figure 65. Global Allogeneic Stem Cell Transplantation Sales Forecast by Application (2025-2030)
Figure 66. Global Allogeneic Stem Cell Transplantation Market Share Forecast by Application (2025-2030)
